share_log

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co.将Alaunos Therapeutics升级为买入,宣布目标股价为1.5美元
Benzinga ·  2023/05/15 07:21

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Alaunos Therapeutics (NASDAQ:TCRT) from Neutral to Buy and announces $1.5 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth将Alaunos Therapeutics(纳斯达克股票代码:TCRT)从中性上调至买入,并宣布了1.5美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发